Manufacturer record

Ipca Laboratory Ltd. Sejavta: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

2 batches manufactured by Ipca Laboratory Ltd. Sejavta were declared Not of Standard Quality between July 2026 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

2 records linked to Ipca Laboratory Ltd. Sejavta in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
2Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Jul 2026 to Jul 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

2
NSQ batches since 2026
1
Products affected
Other
Most common failure
Jul 2026
Latest alert

Flagged batches per year

2026 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Pacimol MF 250 Suspension INCO14030RMfg 2024-09 · Exp 2027-08 Suspension does not dispose uniformaly on shakingOther DTL Jabalpur (M.P.)State lab Jul 2026
Pacimol MF 250 Suspension INCO14035RMfg 2024-10 · Exp 2027-09 Suspension does not dispose uniformaly on shakingOther DTL Jabalpur (M.P.)State lab Jul 2026

Batches reported as suspected spurious under this label

CDSCO's spurious-drug alerts list batches that purport to be made by a company but are suspected counterfeits. The labelled manufacturer's reply is shown where CDSCO published it.

ProductBatchReported byFirm's replyAlert
Aceclofenac 100 mg, Serratiopeptidase 15 mg & Paracetamol 325 mg Tablets Zerodol-SPFND072001BHRDTL, ChandigarhThe actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug.Dec 2025
Aceclofenac 100 mg, Serratiopeptidase 15 mg & Paracetamol 325 mg Tablets ZERODOL-SP TABLETSFND0725001BHRDTL, ChandigarhThe actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug.Dec 2025

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.